InVitria to Present at BIO 2009 International Convention in Atlanta

InVitria to profile "New Strategies for Optimizing CHO Performance" inside the BIO Process Product Zone on May 20, 2009 in Atlanta, GA.

Fort Collins, CO (PRWEB) May 19, 2009 -- Amidst the sea of people, products and presentations at the BIO 2009 International Convention will be InVitria, a cell culture media supplement company that provides performance enhancing components for CHO and hybridoma cell culture media. InVitria's cell culture media supplement products will be part of the BIO Process Product Zone exhibition in Booth #5120 within the Georgia World Congress Center from May 18-21.

InVitria's products will also be showcased in the BioProcess Theater, a site located on the exhibition floor and sponsored by BioProcess International to facilitate the sharing of advances and discoveries in the biopharmaceutical sector. InVitria's Director of Cell Culture, Dr. Steve Pettit, will present the performance enhancing features of ZAP-CHO, a new media component for Chinese hamster ovary (CHO) cell culture. Dr. Pettit will present the advantages of this new cell culture supplement at 3:30 pm on Wednesday, May 20 inside the BioProcess Theater.

ZAP-CHO, a new product from InVitria, enhances performance of mammalian cell culture including improved cell growth and antibody production. It achieves these performance advantages in chemically defined media that are completely free of animal components. Previously, the performance seen with ZAP-CHO was only possible by utilizing animal components such as FBS (fetal bovine serum), BSA (bovine serum albumin) or plasma-derived HSA (human serum albumin) in cell culture media.

"Our team of scientists has developed supplements that not only meet the regulatory requirements of researchers using hybridoma and CHO cell culture, but it exceeds their performance expectations as well," said Dr. Pettit. "InVitria products have been utilized by customers to successfully achieve greater cell productivity and growth; faster cell doublings; and improved consistency."

About InVitria (http://www.InVitria.com):

InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's performance enhancing reagents, contact us at info @ InVitria.com or call 1-800-916-8311.

###